Skip to content

The Prostate Immobilization Device Study

The Prostate Immobilization Device Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01408706
Enrollment
60
Registered
2011-08-03
Start date
2011-08-31
Completion date
2014-10-31
Last updated
2017-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocarcinoma of the Prostate

Brief summary

The purpose of this study is to compare reproducibility of the device position and location of the prostate rectum interface between two immobilization devices for radiation therapy of prostate carcinoma.

Detailed description

The investigator assessed the device position and location of the interface between rectum and prostate weekly during the course of treatment. This information was obtained using a conebeam CT scan on the treatment couch prior to a regularly scheduled radiation treatment. The conebeam CT scan is a standard tool for monitoring patient position and radiation treatment accuracy. Prior to each radiation treatment, the patient was placed in a vaclock immobilization device, then aligned with room lasers to skin tattoos. On board portal imaging was then employed using the KvKv match technique to place isocenter as simulated. For intact prostate treatment, alignment was made to implanted gold fiducial markers. For post prostatectomy patients, the alignment was to pelvic bony anatomy. After patient alignment was complete, a conebeam CT scan was obtained. The position of the anterior rectal wall and the interface between prostate and rectum was compared to the position of these structures at the time of simulation. Measurement was taken in the midline of the prostate gland between its base and apex of the maximum deviation of the rectum prostate interface from its position at the time of simulation. For post prostatectomy patients, a measurement was taken of the maximum deviation from simulation of interface between the rectum and the prostate bed/bladder. These measurements were recorded weekly by the treating radiation oncologist on the Physician Data Sheet. The difficulty of device insertion, positioning and inflation was recorded daily by the treating personnel based on a scale in the PIDS Daily Radiation Therapist Questionnaire, from 1(none) to 5(unable to insert). These results were summarized by the clinical study coordinators on the PIDS Radiation Therapist Summary. Patient expression of discomfort during device placement was recorded daily by treating personnel based on a scale in the PIDS Daily Radiation Therapist Questionnaire, from 1(none) to 5(intolerable). These responses will be summarized by the clinical study coordinators on the PIDS Radiation Therapist Summary.

Interventions

DEVICEMiller Air tip

Miller Enema Air Tip is inserted into rectum prior to simulation and each radiation treatment.

DEVICERadiadyne Immobilizer

Radiadyne Immobilizer is inserted into rectum prior to simulation and each radiation treatment

Sponsors

James Taylor
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Clinically localized T1-3 N0-1 M0 adenocarcinoma of the prostate * Planned definitive radiation therapy

Exclusion criteria

* Prior proctectomy * Rectal surgery within one year * Proctitis * Rectal carcinoma * Anal Stenosis * History of inflammatory bowel disease * Scleroderma * Systemic sclerosis * Refusal of treatment with immobilization device

Design outcomes

Primary

MeasureTime frameDescription
Deviation of the Prostate Rectal Interface From Its Position at Time of Simulation.Up to 9 weeksMeasurements will be taken for at least 5, and up to 9, occasions on a weekly basis during each patient's course of treatment. An average value will be determined for each patient. An average of individual patient values will be determined for each immobilization device.

Secondary

MeasureTime frameDescription
Difficulty of Insertion.Up to nine weeksDifficulty of device insertion was scored for each treatment by the treating radiation therapist on a scale from 1(easiest) to 5(most difficult). An average score was obtained at completion of therapy for each patient. At completion of the study, an average value was obtained for each immobilization device by averaging the average score for each patient .
Patient Expression of DiscomfortUp to nine weeksPatient expression of discomfort was scored for each insertion by the treating radiation therapist on a scale from 1(none) to 5(intolerable). An average score was obtained at completion of therapy for each patient. At completion of the study, an average value was obtained for each immobilization device by averaging the average score for each patient .

Countries

United States

Participant flow

Participants by arm

ArmCount
Miller Enema Air Tip
Use of Miller enema air tip to fix prostate location and displace rectal tissue during radiation therapy. Prostate gland immobilization with rectal balloon: Device: Prostate gland immobilization with rectal balloon (Miller enema air tip or Radiadyne Prostate Immobilizer Treatment Device) to fix prostate location and displace rectal tissue during radiation therapy.
30
Radiadyne Immobilizer Treatment Device
Use of Radiadyne Immobilizer Treatment Device to fix prostate location and displace rectal tissue during radiation therapy Prostate gland immobilization with rectal balloon: Device: Prostate gland immobilization with rectal balloon (Miller enema air tip or Radiadyne Prostate Immobilizer Treatment Device) to fix prostate location and displace rectal tissue during radiation therapy.
30
Total60

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyPhysician Decision10

Baseline characteristics

CharacteristicMiller Enema Air TipRadiadyne Immobilizer Treatment DeviceTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
23 Participants23 Participants46 Participants
Age, Categorical
Between 18 and 65 years
7 Participants7 Participants14 Participants
Clinically localized T1-3, NO, MO adenocarcinoma of the prostate30 participants30 participants60 participants
Region of Enrollment
United States
30 participants30 participants60 participants
Sex: Female, Male
Female
0 Participants0 Participants0 Participants
Sex: Female, Male
Male
30 Participants30 Participants60 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 300 / 30
serious
Total, serious adverse events
0 / 300 / 30

Outcome results

Primary

Deviation of the Prostate Rectal Interface From Its Position at Time of Simulation.

Measurements will be taken for at least 5, and up to 9, occasions on a weekly basis during each patient's course of treatment. An average value will be determined for each patient. An average of individual patient values will be determined for each immobilization device.

Time frame: Up to 9 weeks

ArmMeasureValue (MEAN)Dispersion
Miller Enema Air TipDeviation of the Prostate Rectal Interface From Its Position at Time of Simulation..319 CENTIMETERSStandard Deviation 0.603
Radiadyne Immobilizer Treatment DeviceDeviation of the Prostate Rectal Interface From Its Position at Time of Simulation..095 CENTIMETERSStandard Deviation 0.202
Secondary

Difficulty of Insertion.

Difficulty of device insertion was scored for each treatment by the treating radiation therapist on a scale from 1(easiest) to 5(most difficult). An average score was obtained at completion of therapy for each patient. At completion of the study, an average value was obtained for each immobilization device by averaging the average score for each patient .

Time frame: Up to nine weeks

ArmMeasureValue (MEAN)
Miller Enema Air TipDifficulty of Insertion.1.083808 units on a scale
Radiadyne Immobilizer Treatment DeviceDifficulty of Insertion.1.067535 units on a scale
Secondary

Patient Expression of Discomfort

Patient expression of discomfort was scored for each insertion by the treating radiation therapist on a scale from 1(none) to 5(intolerable). An average score was obtained at completion of therapy for each patient. At completion of the study, an average value was obtained for each immobilization device by averaging the average score for each patient .

Time frame: Up to nine weeks

ArmMeasureValue (MEAN)
Miller Enema Air TipPatient Expression of Discomfort1.138237 units on a scale
Radiadyne Immobilizer Treatment DevicePatient Expression of Discomfort1.087719 units on a scale

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026